RxMP Therapeutics secures DARPA contract worth up to USD10.7m

TNutra launches NeuraLegend brain health supplements

Health Canada approves AbbVie psoriasis treatment for children

WuXi AppTec recognised in Frost & Sullivan's Global Company of the Year awards for Tenth Consecutive Year

Oracle partners AstraZeneca for AI-enabled healthcare innovation

Eli Lilly and Company reports positive one-year results for Omvoh in paediatric ulcerative colitis

AbbVie's dual-targeting Crohn's disease therapy outperforms monotherapies in Phase IIa trial

Takeda trial shows ENTYVIO reduces ulcerative colitis complication risk by nearly 70%

GSK reports 61% response rate for investigational lung cancer drug

UEG introduces new Patient Representatives Advisory Board

Ionis' TRYNGOLZA recommended for EU approval in severe hypertriglyceridemia

FDA approves Genentech's Enspryng as first at-home subcutaneous treatment for thyroid eye disease

Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma

EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer

Edesa Biotech receives FDA clearance to expand EB06 vitiligo study into the US